JC

Jeremy Curtis

VP Worldwide Marketing at ATS Medical, Inc.

Jeremy Curtis has a diverse work experience in various roles and industries. Jeremy started their career at Chiquita Brands International in 1997 as the Director of eCommerce, where they worked until 2000. Jeremy then moved to GE Healthcare in 2003, where they held two different roles - GM of Diagnostic Cardiology Marketing from 2005 to 2007 and GM of Cardiology Asia from 2003 to 2005. After that, they joined ATS Medical, Inc. and served as the VP of Worldwide Marketing.

Jeremy Curtis attended Thunderbird School of Global Management from 1996 to 1997, where they earned a Masters of International Business. Prior to that, they attended Brigham Young University, but no degree or field of study information is available for this period.

Location

Osseo, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


ATS Medical, Inc.

ATS Medical, Inc. is dedicated to 'Advancing The Standards' of cardiac surgery through the development, manufacturing and marketing of innovative products and services for the treatment of structural heart disease. ATS Medical serves the cardiac surgery community by focusing on two distinct but operationally synergistic market segments: heart valve disease therapy and surgical ablation of cardiac arrhythmias. ATS was originally founded to develop the ATS Open Pivot® Heart Valve as a new mechanical heart valve standard of care. Today the Open Pivot heart valve is the preferred mechanical heart valve in many markets around the world and the fastest growing mechanical prosthesis in the market. Building on this legacy and addressing the largest market segment in heart valve therapy, the ATS 3f® brand encompasses an innovative tissue heart valve portfolio to address conventional open surgery requirements as well as the growing demand for less invasive sutureless based procedures. The ATS 3f® portfolio includes offerings at various stages including early product development, pivotal clinical trials, and market commercialization. Completing the portfolio in heart valve therapy is the ATS Simulus® annuloplasty product line. Simulus products assist the surgeon in repairing a patient's native heart valve as an alternative to replacement. Continuing ATS Medical's focus on serving the cardiac surgery community are the ATS CryoMaze(TM) products for surgical cryoablation of cardiac arrhythmias. ATS CryoMaze(TM) products are used by surgeons to treat patients suffering from cardiac arrhythmias, the largest and fastest growing form of structural heart disease in populations over 60 years of age.


Headquarters

United States

Employees

201-500

Links